Therapy News and Research

RSS

Older women with mild retinopathy more likely to have cognitive decline and related vascular changes

Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).

16 Mar 2012

CCN1 protein orchestrates cellular antiviral response in the extracellular matrix

Brain-tumor cells that are infected with a cancer-killing virus release a protein "alarm bell" that warns other tumor cells of the impending infection and enables them to mount a defense against the virus, according to a study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

16 Mar 2012

NEJM publishes results from Teva's laquinimod Phase III study on RRMS

Teva Pharmaceutical Industries Ltd. and Active Biotech today announced the publication of results from the laquinimod Phase III ALLEGRO study in the March 15 issue of The New England Journal of Medicine.

16 Mar 2012

Adverse drug reactions could be avoided among adult hospital and emergency patients

Close to half of adverse reactions to medicines among adult hospital and emergency patients could be avoided, shows a study from the Nordic School of Public Health NHV.

16 Mar 2012

Experts highlight latest advances in use of biomarkers in various diseases

Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.

16 Mar 2012

ThromboGenics, Alcon collaborate to commercialize ocriplasmin outside the US

ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.

16 Mar 2012

$Health Canada grants license to Medtronic DBS Therapy for refractory epilepsy$

Health Canada grants license to Medtronic DBS Therapy for refractory epilepsy

Medtronic, Inc. today announced that it has received from Health Canada a license for Medtronic Deep Brain Stimulation (DBS) Therapy for refractory epilepsy patients.

From Medtronic 16 Mar 2012

GABA neurons could help restore muscle coordination deficits of Huntington's

Huntington's disease, the debilitating congenital neurological disorder that progressively robs patients of muscle coordination and cognitive ability, is a condition without effective treatment, a slow death sentence. But if researchers can build on new research reported this week in the journal Cell Stem Cell, a special type of brain cell forged from stem cells could help restore the muscle coordination deficits that cause the uncontrollable spasms characteristic of the disease.

16 Mar 2012

OHRI, uOttawa to lead first stem cell therapy trial for septic shock

A team of researchers from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa) has been awarded $367,000 from the Canadian Institutes of Health Research (CIHR) and $75,000 from the Stem Cell Network to lead the first clinical trial in the world of a stem cell therapy for septic shock.

16 Mar 2012

Smartphone technology can help assess and treat schizophrenia

Psychiatry is employing smartphone technology as an innovative tool in the assessment and treatment of schizophrenia and other serious mental illness. Prominent in this endeavor is Dror Ben-Zeev, an assistant professor of psychiatry at Dartmouth Medical School and director of the Thresholds-Dartmouth Research Center in Chicago.

16 Mar 2012

High rate of trauma among women with HIV plays a role in the epidemic

Physical violence, sexual abuse and other forms of childhood and adult trauma are major factors fueling the epidemic of HIV/AIDS among American women. Scientists have known for years that traumatized women are at greater risk of becoming infected.

16 Mar 2012

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa.

16 Mar 2012

Patients with early stage MPM may be eligible for aggressive multi-modality therapy

Patients with early stage malignant pleural mesothelioma (MPM), a cancer that develops in the lining of the lungs, may be eligible for aggressive multi-modality therapy involving surgery, radiotherapy and chemotherapy.

16 Mar 2012

Combination therapy may improve life span and motor function of infants with Batten disease

Infants with Batten disease, a rare but fatal neurological disorder, appear healthy at birth. But within a few short years, the illness takes a heavy toll, leaving children blind, speechless and paralyzed. Most die by age 5.

16 Mar 2012

New technique can sensitize cancer cells to radiation

Researchers at Winship Cancer Institute are developing a technique to remove cancer cells' defenses against radiation.

16 Mar 2012

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

CSL Behring announced today that the first patient has been treated as part of the REPLACE Phase III clinical trial evaluating the efficacy and safety of fibrinogen concentrate (Human) (FCH) in controlling microvascular bleeding during aortic aneurysm surgery.

16 Mar 2012

American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the fourth quarter and 2011.

From Elekta 15 Mar 2012

Lose weight to help your child lose weight

A study by researchers at the University of California, San Diego School of Medicine and The University of Minnesota indicates that a parent's weight change is a key contributor to the success of a child's weight loss in family-based treatment of childhood obesity. The results were published today in the advanced online edition of the journal Obesity.

15 Mar 2012

China Pharma revenue increases 9% to $81.2M for full year 2011

China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2011.

15 Mar 2012

Fear of flying can be cured independently of YOH or after 4 sessions of VRET

This randomized controlled trial shows that fear of flying can be cured independently of drug condition [yohimbine hydrochloride (a noradrenaline agonist) or placebo] after 4 sessions of virtual reality exposure therapy (VRET).

15 Mar 2012

Therapy News and Research

Older women with mild retinopathy more likely to have cognitive decline and related vascular changes

CCN1 protein orchestrates cellular antiviral response in the extracellular matrix

NEJM publishes results from Teva's laquinimod Phase III study on RRMS

Adverse drug reactions could be avoided among adult hospital and emergency patients

Experts highlight latest advances in use of biomarkers in various diseases

ThromboGenics, Alcon collaborate to commercialize ocriplasmin outside the US

Health Canada grants license to Medtronic DBS Therapy for refractory epilepsy

GABA neurons could help restore muscle coordination deficits of Huntington's

OHRI, uOttawa to lead first stem cell therapy trial for septic shock

Smartphone technology can help assess and treat schizophrenia

High rate of trauma among women with HIV plays a role in the epidemic

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Patients with early stage MPM may be eligible for aggressive multi-modality therapy

Combination therapy may improve life span and motor function of infants with Batten disease

New technique can sensitize cancer cells to radiation

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

Lose weight to help your child lose weight

China Pharma revenue increases 9% to $81.2M for full year 2011

Fear of flying can be cured independently of YOH or after 4 sessions of VRET

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News